位置:成果数据库 > 期刊 > 期刊详情页
丹参酮IIA磺酸钠注射液防治奥沙利铂诱导的周围神经病变的临床观察
  • ISSN号:1001-859X
  • 期刊名称:中药药理与临床
  • 时间:2014.10.15
  • 页码:134-136
  • 分类:R286.0[医药卫生—中药学;医药卫生—中医学]
  • 作者机构:[1]湖北省武汉市第一医院肿瘤科,武汉430020, [2]华中科技大学同济医学院附属同济医院骨科,武汉430030
  • 相关基金:国家自然科学基金项目(No.81202121); 武汉市卫生局科研项目(No.WX12C07)
  • 相关项目:PTHrP/Wnt双信号通路在软骨肉瘤细胞中交互作用机制及去分化调控研究
中文摘要:

目的:观察丹参酮IIA磺酸钠注射液对奥沙利铂诱导的外周神经毒性的防治作用。方法:入选36例病例均为含有奥沙利铂的化疗方案,随机平分为丹参酮治疗组和化疗组。化疗组均接受含有奥沙利铂130mg/m2*d1的化疗方案,每21天重复一次,按期化疗4周期。丹参酮治疗组在用奥沙利铂前加用丹参酮IIA磺酸钠80mg加入5%葡萄糖液500ml中静脉滴注,每天1次,连用3天。完成4个周期后评价外周神经病变程度,并分别检测两组治疗前后丙二醛(MDA)含量、超氧化物歧化酶(SOD)活性、腓总神经传导速度MNCV和SNCV。结果:其中丹参酮治疗组外周神经毒性发生率27.8%,化疗组外周毒性总发生率55.6%,两组差异有显著性。化疗后丹参酮治疗组腓总神经传导速度明显增快,MDA含量(6.31±2.74μmol/L)显著低于对照组(11.66±3.50μmol/L),而丹参酮治疗组SOD活性(79.51±7.96k U/L)明显高于对照组(42.24±10.79 k U/L)。结论:丹参酮IIA磺酸钠能降低奥沙利铂神经毒性的发生,可能是通过启动抗氧化作用,发挥神经保护功能。

英文摘要:

Objective: To observe the preventive effect of sodium tanshinone IIA sulfonate on oxaliplatin induced peripheral neurotoxicity. Methods: 36 cases were chemotherapy containing oxaliplatin,randomly divided into tanshinone treatment group and chemotherapy group. Chemotherapy group were recieved chemotherapy containing oxaliplatin 130 mg / m2* d1,repeated every 21 days,on schedule to 4 cycles. Tanshinone treatment group was added with sodium tanshinone IIA sulfonate 80 mg in 5% glucose 500 ml iv during the chemotherapy of oxaliplatin,1 times per day for 3 days. After chemotherapy 4 cycles,peripheral neuropathy degree evaluation were detected before and after treatment in two groups,and the malondialdehyde( MDA) content,superoxide dismutase( SOD) activity,common peroneal nerve conduction velocity of MNCV and SNCV were detected individually. Results: The peripheral neurotoxicity incidence of tanshinone group was 27. 8%,which of chemotherapy group was 55. 6%,there was significant difference between two groups( P 〈 0. 05). The peroneal nerve conduction velocity of tanshinone treatment group was faster than that of the control group,and the content of MDA( 6. 31 ± 2. 74μmol / L) was significantly lower than that of the control group( 11. 66 ± 3. 50μmol / L)( P 〈 0. 05),but the SOD activity of tanshinone therapy group( 79. 51 ± 7. 96 k U / L)was significantly higher than the control group( 42. 24 ± 10. 79 k U / L)( P 〈 0. 05). Conclusion: Sodium tanshinone IIA sulfonate can reduce the occurrence of neurotoxicity of oxaliplatin,probably by starting the antioxidant effect,exert neuroprotective function.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中药药理与临床》
  • 北大核心期刊(2011版)
  • 主管单位:中国省中医管理局
  • 主办单位:四川中药研究所 中国药理学会
  • 主编:邓文龙
  • 地址:成都市人民南路4段51号
  • 邮编:610041
  • 邮箱:zyyl707@163.com
  • 电话:028-85234707
  • 国际标准刊号:ISSN:1001-859X
  • 国内统一刊号:ISSN:51-1188/R
  • 邮发代号:
  • 获奖情况:
  • 自然科学核心期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:28884